Xu Zhu
Corporate Officer/Principal en EVEREST MEDICINES LIMITED .
Perfil
Xu Zhu is currently the Director at EverID Medicines Ltd.
and the Chief Medical Officer-Infectious Disease at Everest Medicines Ltd.
She previously worked as the Executive Director-Drug Development at AstraZeneca UK Ltd.
and Astrazeneca Pharmaceutical Technology Beijing Co. Ltd.
from 2003 to 2013.
Prior to that, she was the Manager-Clinical Research at MSD China Holding Co. Ltd.
from 1995 to 2003.
Ms. Zhu received her graduate degree from Peking University Health Science Center in 2009 and her undergraduate degree from Beijing Medical University in 1994.
Cargos activos de Xu Zhu
| Empresas | Cargo | Inicio |
|---|---|---|
| EVEREST MEDICINES LIMITED | Corporate Officer/Principal | 01/10/2017 |
| EverID Medicines Ltd. | Director/Board Member | - |
Antiguos cargos conocidos de Xu Zhu.
| Empresas | Cargo | Fin |
|---|---|---|
| Astrazeneca Pharmaceutical Technology Beijing Co. Ltd. | Corporate Officer/Principal | 01/04/2013 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/04/2013 |
| MSD China Holding Co. Ltd. | Corporate Officer/Principal | 01/01/2003 |
Formación de Xu Zhu.
| Peking University Health Science Center | Graduate Degree |
| Beijing Medical University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EVEREST MEDICINES LIMITED | Health Technology |
| Empresas privadas | 4 |
|---|---|
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
| MSD China Holding Co. Ltd. | |
| EverID Medicines Ltd. | |
| Astrazeneca Pharmaceutical Technology Beijing Co. Ltd. |
- Bolsa de valores
- Insiders
- Xu Zhu
